Dysregulation of mitochondrial function in the context of obesity can participate not only in the cardiac consequences of obesity, but as well as in its metabolic ones, since the administration of a mitochondrial antioxidant was able to improve cardiac damage and improve insulin resistance in adipose tissue associated with obesity [10,12,13,14]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.